Eastwood Bio Medical Canada Stock Cash And Equivalents
| EBM Stock | CAD 0.75 0.05 6.25% |
Eastwood Bio Medical Canada fundamentals help investors to digest information that contributes to Eastwood Bio-Medical's financial success or failures. It also enables traders to predict the movement of Eastwood Stock. The fundamental analysis module provides a way to measure Eastwood Bio-Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastwood Bio-Medical stock.
Eastwood | Cash And Equivalents |
Eastwood Bio Medical Canada Company Cash And Equivalents Analysis
Eastwood Bio-Medical's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Eastwood Bio-Medical Cash And Equivalents | 708.26 K |
Most of Eastwood Bio-Medical's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastwood Bio Medical Canada is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Eastwood Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Eastwood Bio-Medical is extremely important. It helps to project a fair market value of Eastwood Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Eastwood Bio-Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Eastwood Bio-Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Eastwood Bio-Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Eastwood Bio Medical Canada has 708.26 K in Cash And Equivalents. This is 99.91% lower than that of the Consumer Staples Distribution & Retail sector and 99.84% lower than that of the Consumer Staples industry. The cash and equivalents for all Canada stocks is 99.97% higher than that of the company.
Eastwood Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastwood Bio-Medical's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastwood Bio-Medical could also be used in its relative valuation, which is a method of valuing Eastwood Bio-Medical by comparing valuation metrics of similar companies.Eastwood Bio is currently under evaluation in cash and equivalents category among its peers.
Eastwood Bio-Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Eastwood Bio-Medical from analyzing Eastwood Bio-Medical's financial statements. These drivers represent accounts that assess Eastwood Bio-Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Eastwood Bio-Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 78.2M | 84.1M | 82.7M | 114.7M | 103.2M | 79.5M | |
| Enterprise Value | 78.1M | 84.1M | 82.7M | 114.7M | 103.2M | 78.8M |
Eastwood Fundamentals
| Return On Equity | -7.47 | ||||
| Return On Asset | -0.64 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.51) % | ||||
| Current Valuation | 51.72 M | ||||
| Shares Outstanding | 68.89 M | ||||
| Shares Owned By Insiders | 69.55 % | ||||
| Number Of Shares Shorted | 63 | ||||
| Price To Earning | (11.43) X | ||||
| Price To Book | 2,943 X | ||||
| Price To Sales | 79.05 X | ||||
| Revenue | 867.94 K | ||||
| Gross Profit | 902.74 K | ||||
| EBITDA | (398.19 K) | ||||
| Net Income | (546.6 K) | ||||
| Cash And Equivalents | 708.26 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 23.08 K | ||||
| Current Ratio | 3.42 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (16.89 K) | ||||
| Short Ratio | 0.05 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 0.28 | ||||
| Market Capitalization | 51.66 M | ||||
| Total Asset | 489.14 K | ||||
| Retained Earnings | (5.54 M) | ||||
| Working Capital | (1.18 M) | ||||
| Net Asset | 489.14 K |
About Eastwood Bio-Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastwood Bio Medical Canada's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastwood Bio-Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastwood Bio Medical Canada based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.